Emily K. Hill, MD

Portrait
Clinical Assistant Professor of Obstetrics and Gynecology - Gynecologic Oncology

Contact Information

319-356-2015

Education

BA, Russian Studies, Brown University
MD, Medical School, University of Wisconsin School of Medicine and Public Health
Resident, Obstetrics and Gynecology, University of Chicago Hospitals
Fellow, Gynecologic Oncology and Breast Surgery, Brown University/Women & Infants Hospital

Licensure and Certifications

American Board of Obstetrics and Gynecology, Yearly Recertification
Medical License (Iowa), MD-42703

Publications

Beffa, L., Cantillo, E., Stuckey, A., Hill, E., Brown, A., Gordinier, M., Raker, C., Clark, M. & Robinson, K. (In Press). Assisted reproductive technology use among female gynecologic oncologists.

Stuckey, A., Hill, E., Fiascone, S., Brown, A., Gordinier, M., Luis, C., Raker, C., Clark, M. & Robison, K. (In Press). A change in the balance between personal and professional life among female gynecologic oncologists. Clinical Obstetrics, Gynecology and Reproductive Medicine (Accepted).

McDonald, M., Mattson, J. & Hill, E. K. (2017). Profound sensorineural hearing loss after one cycle of intraperitoneal cisplatin in treatment of advanced ovarian cancer. Gynecologic Oncology Reports, 20, 103-104. PMID: 28393095.

Cass, I., Duska, L. R., Blank, S. V., Cheng, G., duPont, N. C., Frederick, P. J., Hill, E. K., Matthews, C. M., Pua, T. L., Rath, K. S., Ruskin, R., Thacker, P. H., Berchuck, A., Gostout, B. S., Kushner, D. M. & Fowler, J. M. (2016). Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and Recommendations. Gynecol Oncol, 143(2), 421-427. PMID: 27575910.

Hill, E. K., Stuckey, A. S., Fiascone, S., Brown, A., Gordinier, M., Raker, C. & Robison, K. (2016). Current Mentorship Practices in Gynecologic Oncology. Poster presentation at 2016 ACOG Annual Meeting, Washington DC, May 14-18, 2016.

Stuckey, A., Hill, E. K., Fiascone, S., Brown, A., Gordinier, M., Raker, C. & Robison, K. (2016). Changing the Balance Between Personal and Professional Life among Female Gynecologic Oncologists—1998 vs. 2015. Poster presentation at SGO Annual Meeting in San Diego, CA, March 19-22, 2016..

Stuckey, A., Hill, E. K., Fiascone, S., Brown, A., Gordinier, M., Raker, C. & Robison, K. (2016). What is the Impact of a Career in Gynecologic Oncology on Personal Life?. Poster presentation at SGO Annual Meeting in San Diego, CA, March 19-22, 2016..

Hill, E. K., Blake, R. A., Emerson, J. B., Svider, P., Eloy, J. A., Raker, C., Robinson, K. & Stuckey, A. (2015). Gender Differences in Scholarly Productivity Within Academic Gynecologic Oncology Departments. Obstet Gynecol, 126(6), 1279-84. PMID: 26551177.

Guthrie, M. L., Sidhu, P. S., Hill, E. K., Horan, T. C., Nandhikonda, P., Teske, K. A., Yuan, N. Y., Sidorko, M., Rodali, R., Cook, J. M., Han, L., Silvaggi, N. R., Bikle, D. D., Moore, R. G., Singh, R. K. & Arnold, L. A. (2015). Antitumor Activity of 3-Indolylmethanamines 31B and PS121912. Anticancer Res, 35(11), 6001-7. PMID: 26504023.

Hill, E. K., Miller, M. C., Horan, T., Singh, R., Kawar, N., Eklund, E., Messerlain, G., Hawkins, D., McCourt, C., Allard, W. J., Granai, C. O. & Moore, R. G. (2014). A Novel Biomarker for the Management of Women Diagnosed with Endometrial Adenocarcinoma.

Lokich, E., Hill, E. K., Han, A., Romano, N., Yano, N., Kim, K., Hovanessian, G., Singh, R. & Moore, R. G. (2014). Treatment of Epithelial Ovarian Cancer with HE4-targeted antisense phosphorothioligos (PTO’s).

Hill, E. K., Steinhoff, M., Raker, C. & Disilverstro, P. (2014). Tumor Microvessel Density Does Not Correlate with Bevacizumab Response in Recurrent Ovarian Cancer.

Moore, R. G., Hill, E. K., Horan, T., Yano, N., Kim, K., MacLaughlan, S., Lambert-Messerlian, G., Tseng, Y. D., Padbury, J. F., Miller, M. C., Lang, T. S. & Singh, R. K. (2014). HE4 (WFDC2) gene overexpression promotes ovarian tumor growth. Nature Scientific Reports,(4), 3574.

Hill, E. K., Singh, R., Horan, T., Yano, N., Chu, S., Mao, Q., Kim, K., Lange, T., Lambert-Messerlian, G. & Moore, R. (2013). The molecular role of the HE4 (WFDC2) gene in ovarian cancer tumorigenesis.

Hill, E. K., Steinhoff, M., Raker, C. & Disilverstro, P. (2013). Tumor Microvessel Density Does Not Correlate with Bevacizumab Response in Recurrent Ovarian Cancer.

Hill, E. K., Singh, R., Horan, T., Yano, N., Chu, S., Mao, Q., Kim, K., Lange, T., Lambert-Messerlian, G. & Moore, R. (2013). The oncogenic role of human epididymis (HE4): promotion of tumorigenesis, cell survival and cisplatin resistance in ovarian cancer in an in vivo mouse model.

Hill, E. K., Raker, C., Carson, S., Wiggins, D., Granai, C. O., Gass, J. S., Spriggs, E. & Dizon, D. S. (2012). Sexual Dysfunction, Depression and Quality of Life in Breast and Gynecologic Cancer Survivors: A Prospective Evaluation.

Hill, E. K., Gass, J. S., Raker, C., Carson, S., Wiggins, D., Granai, C. O., Spriggs, E. & Dizon, D. S. (2012). Sexual Dysfunction, Depression and Quality of Life in Breast and Gynecologic Cancer Survivors: A Prospective Evaluation.

Barlin, J. N., Yu, C., Hill, E. K., Zivanovic, O., Kolev, V., Levine, D. A., Sonoda, Y., Abu-Rustum, N. R., Huh, J., Barakat, R. R., Kattan, M. W. & Chi, D. S. (2012). Nomogram for Predicting Five-Year Disease-Specific Mortality after Primary Surgery for Epithelial Ovarian Cancer. Gynecol Oncol, 125(1), 25-30.

Hill, E. K., Dizon, D. S. (2012). Medical Therapy of Endometrial Cancer: Current status and promising novel treatments. Drugs, 72(5), 705-13.

Hill, E. K., Raker, C., Carson, S., Wiggins, D., Granai, C. O., Gass, J. S., Spriggs, E. & Dizon, D. S. (2012). Prospective Evaluation of Quality of Life, Sexual Function, and Depression in Women Referred to a Sexuality Clinic for Female Cancer Survivors.

Hill, E., Kawar, N., King, H., Rizack, T. & Gass, J. (2012). Basics of Adjuvant Therapy for Breast Cancer. L. G. Wilke , A. Chagpar (Eds.) ASBS Handbook of Breast Surgery.

Hill, E. K., Sandbo, S., Abramsohn, E., Makelarski, J., Wroblewski, K., Wenrich, E. R., McCoy, S., Temkin, S. M., Yamada, S. D. & Lindau, S. T. (2011). Assessing Gynecologic and Breast Cancer Survivors Sexual Health Care Needs. Cancer, 117(2), 2643-2651.

Hill, E. K., Brady, W. E., Birrer, M. J., Darch, K. M., McGuire, W. P., Hoskins, W. J., Warshal, D. P., Drake, R. D., Hanjani, P. & Hurteau, J. A. (2011). Cyclin D1 and p57 Expression in Advanced Ovarian Carcinoma: A GOG Study.

Hill, E. K., Sandbo, S., Abramsohn, E., Wenrich, E. R., McCoy, S., Temkin, S. M., Yamada, S. D. & Lindau, S. T. (2010). Assessing Gynecologic Cancer Survivors’ Sexual Health Care Needs.

Dale, W., Hemmerich, J., Hill, E. K., Hougham, G. W. & Sachs, G. A. (2008). What Correlates With the Intention to be Tested for Mild Cognitive Impairment (MCI) in Healthy Older Adults?. Alzheimer Dis Assoc Disord, 22(2), 144-152.

Dale, W., Hougham, G. W., Hill, E. K. & Sachs, G. A. (2006). “High Interest in Screening and Treatment for Mild Cognitive Impairment in Older Adults: A Pilot Study. Journal of the American Geriatric Society, 54(9), 1388-94.

Hill, E. K., Dale, W., Hougham, G. W., Stocking, C. & Sachs, G. A. (2004). Factors Predicting Intention to be Screened for Mild Cognitive Impairment (MCI): Instrument Development.